RARA CRAFT DATABASE for FDA Medical Devices
510(k)K240875

FDA DEVICE FACTS

Unity Knee PS-C Tibial Insert

Corin U.S.A. Limited

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 26, 2024PRODUCT CODEJWH

Indications for use

The Unity Knee™ PS-C Tibial Insert is intended for use in the Unity Total Knee System, in total knee arthroplasty in skeletally mature patients, to provide increased mobility and reduce pain by replacing the damaged knee joint articulation where there is evidence of suff icient sound bone to seat and support the components. The General total knee arthroplasty indications include:

• Painful, disabling joint disease of the knee resulting from: degenerative arthritis, rheumatoid arthritis or post-traumatic arthritis

• Post-traumatic loss of knee joint configuration and function

• Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function

• Revision of previous unsuccessful knee replacement or other procedure, where soft tissue stability is adequate

• Fracture of the distal femur and/or proximal tibia that cannot be stabilized by standard fracture management techniques

• The posterior stabiIized variant is also indicated for PCL instability requiring implant bearing surface geometries with increased anterior -posterior constraint and absent or non -functioning posterior cruciate ligament The Unity Total Knee System is intended for cemented use, single use only. Indications for Use Comparison The Unity Knee PS-C tibial insert is identical to the Apex PS-C insert (K111184) and the Unity Knee PS tibial insert (K113060) in terms of intended use. The Unity Knee PS-C tibial insert indications for use are identical to the indications for use of the Unity Knee PS tibial insert. The Unity Knee PS -C tibial insert indications for use are similar to the indications for use of the Apex PS-C insert; they fall within the intended use of the predicate device and the differences do not alter the intended therapeutic use of the subject dev ice nor do they affect the safety and effectiveness of the device relative to the predicate. K240875 (Page 2 of 3)

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 17, 2026